Read + Share
Duran E, Yildirim BES, Karadag O. Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder
patients with rheumatoid arthritis by Humby et al. Clin Exp Rheumatol 2021 Sep 7. pii: 17387.
PMID: 34494954
|
 |
|
Duran E, Yildirim BES, Karadag O. Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder
patients with rheumatoid arthritis by Humby et al. Clin Exp Rheumatol 2021 Sep 7. pii: 17387.
PMID: 34494954
|
|
|
|